Trial of Adjuvant Chemoradiation After Gastric Resection For Adenocarcinoma, Phase III
Publication Information Expand/Collapse
PMid: PMID29370458 | PMC number: PMC5963502
Survival by Hispanic Ethnicity Among Cancer Patients participating in SWOG Clinical Trials
PMid: PMID28586789; PMC5710507
PMid: PMID24627276 | PMC number: PMC3982777
PMid: PMID23524864 | PMC number: PMC3690906
PMid: PMID23669424 | PMC number: PMC4131693
Updated analysis of SWOG-directed Intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation following curative gastric resection (CALGB-9195; ECOG-6290; NCCTG-90-41; RTOG 9018 and SWOG-9008
PMid: PMID2258569 | PMC number: PMC4517071
Assessment of HER2 Gene Amplification in Adenocarcinomas of the Stomach or Gastroesophageal Junction in the INT-0116/SWOG9008 Clinical Trial
Gastric Cancer: Nagoya is not New York [PMID22010021]
Chemoradiation of resected gastric cancer: a 10 year followup of INT0116 (SWOG 9008)
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): research objectives workshop 2008 [PMID19723641; PMC2978526]
The Southwest Oncology Group: progress in cancer research [PMID18929152]
Improved regional control and survival with "low maruyama index" surgery in gastric cancer: autopsy findings from the Dutch D1-D2 trial [PMID17336241]
Gastric cancer: D2 dissection or low maruyama index-based surgery - a debate [PMID17336241]
Low maruyama index surgery for gastric cancer [PMID17577616]
Evidence-based recommendations for local-regional control of gastric cancer
Chapter 45 - Stomach
Changing gastric cancer treatment in the United States and the pursuit of quality
Low maruyama index surgery for gastric cancer: blinded re-analysis of the Dutch D1-D2 trial
Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall sirvival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: update o fthe results of Intergroup study INT-0116 (SWOG 9008)
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis PMID:15067027
Intergroup 0144: A phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): mature outcome results and pelvic failure analysis
Frequent alterations of B-catenin gene in gastric cancers with microsatellite instability
Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003 PMID14528084
B-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer
B-Catenin nuclear staining and mutation in gastric cancer
Beta-catenin is commonly mutated in human gastric cancers with cyclin D overexpression.
Mutation of the B-catenin gene is a frequent cause of Wnt pathway activation in gastric cancer.
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.
Surgical quality in trials of adjuvant cancer therapy
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
E-Cadherin, a and b-catenins in gastric cancer expression
Alterations in exon 4 of the p53 gene in gastric carcinoma
Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. results of Intergroup study INT-0116 (SWOG 9008)
Intergroup 0116 (SWOG 9008)- Phase III trial of postoperative adjuvant radiochemotherapy for high risk gastric and gastroesophageal (GE) junction adenocarcinoma (ACA): evaluation of efficacy and radiotherapy treatment planning
Thioredoxin, a putative oncogene product is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival
A simple classification of gastric cancer
p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
The relation of p53 gene mutations to gastric cancer subsite and phenotype.
Alterations in exon 4 of the p53 gene in gastric cancer.
Minisatellite instability in gastric cancer
Inadequate documentation and resection for gastric cancer in the United States: A preliminary report.
Detection of microsatellite instability and p53 gene mutations in advanced gastric carcinomas.
Immunohistochemical analysis of bcl-2 family proteins in adenocarcinomas of the stomach.
Pathologic and phenotypic features of gastric cancer.